SCHEMBL6986006

SCHEMBL6986006

CC(=O)N(Cc1ccccc1)c1ccc2c(c1)CCCN2C(=O)CCc1ccc(C#N)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR3C1 P04150 1/20 0.46
ALDH1A1 P00352 4/20 0.45
MEN1 O00255 3/20 0.45
KMT2A Q03164 3/20 0.45
HPGD P15428 2/20 0.45
LMNA P02545 1/20 0.44
TP53 P04637 3/20 0.42
TSHR P16473 4/20 0.42
MAPT P10636 3/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
GAA P10253 1/20 0.42
ALOX15 P16050 1/20 0.42
CASP1 P29466 1/20 0.42
HTT P42858 1/20 0.42
USP2 O75604 1/20 0.42
HSD17B10 Q99714 1/20 0.42
AR P10275 1/20 0.41
NPC1 O15118 3/20 0.41
MAPK1 P28482 2/20 0.41
RAB9A P51151 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6985998 0.90 NR3C1 (0.47) NR3C1ALDH1A1MEN1KMT2AHPGD
SCHEMBL6981593 0.89 LTB4R2 (0.52) NR3C1ALDH1A1MEN1KMT2AHPGD
SCHEMBL6987628 0.87 NR3C1 (0.48) NR3C1ALDH1A1MEN1KMT2AHPGD
SCHEMBL6980751 0.87 NOTUM (0.44) NR3C1ALDH1A1MEN1KMT2AHPGD
SCHEMBL6979167 0.87 KDM1A (0.47) NR3C1ALDH1A1MEN1KMT2AHPGD
SCHEMBL7948753 0.86 ALDH1A1 (0.44) NR3C1ALDH1A1MEN1KMT2AHPGD
SCHEMBL7962885 0.85 NR3C1 (0.41) NR3C1ALDH1A1MEN1KMT2AHPGD
Hydrochloric Acid SCHEMBL6984887 0.85 ALDH1A1 (0.43) NR3C1ALDH1A1MEN1KMT2AHPGD
SCHEMBL6981025 0.85 MEN1 (0.57) NR3C1ALDH1A1MEN1KMT2AHPGD
SCHEMBL6984164 0.84 KDM1A (0.43) NR3C1ALDH1A1MEN1KMT2AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0991624-B1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT BOEHRINGER INGELHEIM PHARMA (DE) 2003-11-19 EP disclosed
US-6300342-B1 FOR THERAPY OR INHIBITING THROMBUS FORMATION; FOR THERAPY OF FIBRIN-DEPENDENT INFLAMMATORY CONDITION BOEHRINGER INGELHEIM PHARM KG (DE) 2001-10-09 US disclosed
EP-0991624-A1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT Boehringer Ingelheim Pharma KG (DE) 2000-04-12 EP disclosed
WO-1999000371-A1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT BOEHRINGER INGELHEIM PHARMA KG (DE) 1999-01-07 WO disclosed